BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7832519)

  • 1. Optimization of a fed-batch process for production of a recombinant antibody.
    Robinson DK; Seamans TC; Gould SL; DiStefano DJ; Chan CP; Lee DK; Bibila T; Glazomitsky K; Munshi S; Daugherty B
    Ann N Y Acad Sci; 1994 Nov; 745():285-96. PubMed ID: 7832519
    [No Abstract]   [Full Text] [Related]  

  • 2. Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.
    Wang HW; Cole D; Jiang WZ; Jin HT; Fu N; Chen ZL; Jin NY
    Clin Exp Immunol; 2005 Jul; 141(1):72-80. PubMed ID: 15958072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of NS0 cell metabolic behavior in monoclonal antibody producing clones.
    Bibila T; Ranucci C; Glazomitsky K; Buckland B; Aunins J
    Ann N Y Acad Sci; 1994 Nov; 745():277-84. PubMed ID: 7832518
    [No Abstract]   [Full Text] [Related]  

  • 4. Cloning and characterization of 1116NS19.9 heavy and light chain cDNAs and expression of antibody fragments in Escherichia coli.
    Tonge DW; Hennam JF; Greene AR; Lee ID; Edge MD
    Year Immunol; 1993; 7():56-62. PubMed ID: 8372513
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities.
    Babcook JS; Leslie KB; Olsen OA; Salmon RA; Schrader JW
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7843-8. PubMed ID: 8755564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies.
    Li J; Menzel C; Meier D; Zhang C; Dübel S; Jostock T
    J Immunol Methods; 2007 Jan; 318(1-2):113-24. PubMed ID: 17161420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of variable heavy and light chain regions of five HIV type 1-specific human monoclonal antibodies.
    van der Donk EM; Schutten M; Osterhaus AD; van der Heijden RW
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1639-49. PubMed ID: 7888223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward more efficient protein expression: keep the message simple.
    Kalwy S; Rance J; Young R
    Mol Biotechnol; 2006 Oct; 34(2):151-6. PubMed ID: 17172660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody repertoire against HIV-1 gp120 triggered in nude and normal mice by GM-CSF/gp120 immunization.
    del Real G; Llorente M; Lucas P; Kremer L; Torán JL; Martínez-A C
    Mol Immunol; 1999 Aug; 36(11-12):721-31. PubMed ID: 10593511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of functional cDNA genes of a mouse/human chimeric antibody rcM4.
    Boyd M; Xiang J
    Tumori; 1994 Dec; 80(6):473-9. PubMed ID: 7900239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody.
    Marasco WA; Haseltine WA; Chen SY
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7889-93. PubMed ID: 8356098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and characterization of a fusion protein of single-chain anti-carcinoma antibody 323/A3 and human beta-glucuronidase.
    Haisma HJ; Brakenhoff RH; vd Meulen-Muileman I; Pinedo HM; Boven E
    Cancer Immunol Immunother; 1998 Jan; 45(5):266-72. PubMed ID: 9439650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and self-assembly of a functional monoclonal antibody in transgenic Nicotiana tabacum.
    Düring K; Hippe S; Kreuzaler F; Schell J
    Plant Mol Biol; 1990 Aug; 15(2):281-93. PubMed ID: 2129424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.
    Major JG; Liou RS; Sun LK; Yu LM; Starnes SM; Fung MS; Chang TW; Chang NT
    Hum Antibodies Hybridomas; 1994; 5(1-2):9-17. PubMed ID: 7858187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and purification of domain-deleted immunoglobulin variants of the recombinant/chimeric B72.3 (y1) monoclonal antibody.
    Calvo B; Kashmiri SV; Hutzell P; Hand PH; Slavin-Chiorini DC; Schlom J; Zaremba S
    Cancer Biother; 1993; 8(1):95-109. PubMed ID: 7529083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of chimeric immunoglobulin genes in mammalian cells.
    Deyev SM; Polanovsky OL
    Methods Mol Biol; 1995; 51():251-63. PubMed ID: 7581702
    [No Abstract]   [Full Text] [Related]  

  • 17. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.
    Couto JR; Blank EW; Peterson JA; Ceriani RL
    Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and assembly of a full-length monoclonal antibody in plants using a plant virus vector.
    Verch T; Yusibov V; Koprowski H
    J Immunol Methods; 1998 Nov; 220(1-2):69-75. PubMed ID: 9839927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response to HIV gp120 induced by nucleic acid immunization (NAI).
    Peet N; Delves PJ; de Souza B; Cambridge G; Wilkinson L; Klonisch T; Matear P; Vyakarnam A; Lund T
    Ann N Y Acad Sci; 1995 Nov; 772():257-60. PubMed ID: 8546402
    [No Abstract]   [Full Text] [Related]  

  • 20. A plasmid system for high-level expression and in vitro processing of recombinant proteins.
    Pohlner J; Krämer J; Meyer TF
    Gene; 1993 Aug; 130(1):121-6. PubMed ID: 8344518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.